Robotic Versus Laparoscopic Complex Elective Cholecystectomy: Balancing Outcomes and Costs

Highlight

• Robotic cholecystectomy significantly reduces the need for unplanned postoperative interventions in complex elective cholecystectomy (CEC) patients compared to laparoscopic methods.
• Despite higher operating room costs, robotic surgery does not increase overall hospital costs for CEC cases.
• No significant outcome differences were observed between robotic and laparoscopic approaches in non-complex elective cholecystectomies.
• These findings support the strategic use of robotic platforms in complex gallbladder surgeries to optimize clinical outcomes and cost-effectiveness.

Study Background

Complex elective cholecystectomy (CEC) presents significant technical challenges due to complicated gallbladder pathology such as prior partial or aborted cholecystectomy, presence of cholecystostomy tubes, or history of gallbladder perforation or fistula. These conditions increase risks for postoperative complications and procedural difficulties. Traditional laparoscopic cholecystectomy has been the standard of care; however, the advent of robotic-assisted surgery has introduced alternative approaches that may offer enhanced dexterity and visualization. Despite rising use, the comparative clinical benefits and economic implications of robotic versus laparoscopic approaches in CEC remain inadequately defined.

Study Design

This cohort study analyzed data from an academic hepatobiliary referral center spanning six years (August 2018 – August 2024). The population included 863 patients undergoing elective cholecystectomy categorized into CEC or non-CEC based on preoperative criteria indicating complex disease. Interventions compared were robotic-assisted cholecystectomy versus conventional laparoscopic cholecystectomy.

The primary composite endpoint was unplanned postoperative interventions requiring endoscopic retrograde cholangiopancreatography (ERCP) or interventional radiology. Secondary outcomes included operative duration, postoperative complications, and detailed cost analyses encompassing operative and total hospital expenses.

Key Findings

Among the 863 patients, 525 (60.8%) were female, and the median age was 61 years (IQR 45-71). In patients undergoing CEC, the laparoscopic approach correlated with a significantly higher likelihood of requiring unplanned postoperative interventions compared with robotic surgery (odds ratio 4.24; 95% CI 1.24-14.52; P = .02). This suggests that robotic assistance may effectively mitigate complications or technical failures necessitating subsequent procedures.

No statistically significant differences in postoperative outcomes were observed between robotic and laparoscopic methods in non-CEC patients, indicating comparable safety and efficacy in routine cases.

Cost analyses revealed that while operating room costs were consistently higher for robotic procedures in both CEC and non-CEC groups ($8,936 vs $7,720 in CEC; $8,351 vs $6,368 in non-CEC), the total hospital costs for CEC did not differ significantly between robotic and laparoscopic approaches ($14,476 vs $14,309, respectively). In contrast, robotic non-CEC cases incurred significantly higher overall costs than laparoscopic non-CEC ($11,416 vs $9,925). This disparity underscores that total cost impact largely depends on complexity and the potential cost offset via reduced complications in CEC.

Expert Commentary

The study provides compelling evidence that robotic platforms confer clinical advantages in managing complex gallbladder pathology by reducing downstream interventions, which can improve patient outcomes and potentially avoid additional morbidity. The increased dexterity and enhanced visualization offered by robotic systems likely facilitate safer dissection in challenging anatomical scenarios.

However, the higher upfront operating room costs for robotic surgery remain a significant consideration. Cost neutrality in total hospital expenses observed here for CEC suggests that the higher initial investment may be counterbalanced by fewer complications and less utilization of postoperative resources. This finding aligns with other studies highlighting the economic viability of robotic surgery in select complex procedures.

Limitations include the single-center design and potential institutional expertise bias, which may limit generalizability. Further multi-institutional randomized studies would strengthen evidence. Additionally, long-term outcomes such as quality of life or functional recovery were not assessed.

Conclusion

Robotic-assisted cholecystectomy for complex elective cases exhibits a clear clinical benefit by reducing unplanned postoperative interventions without increasing total hospital costs. This contrasts with non-complex cases where robotic surgery yields no outcome advantage and higher total costs. These findings advocate for a tailored surgical approach, reserving robotic technology for high-complexity gallbladder cases to maximize patient benefit and maintain resource efficiency.

Integrating robotic systems strategically may enhance surgical care quality in complex scenarios while ensuring sustainable healthcare expenditures. Future research should focus on validating these results across diverse clinical settings and exploring long-term patient-centered outcomes.

Funding and ClinicalTrials.gov

The original study did not disclose specific funding sources or clinical trial registration. Further inquiries may be directed to the authors via the published article link.

References

1. Caldwell KE, Threlkeld E, Litrel J, Brocke T, Fields RC, Panni RZ, Nguyen T, Leigh N, Sanford DE. Outcomes and Costs After Robotic vs Laparoscopic Complex Elective Cholecystectomy. JAMA Surg. 2026 Jul 15; PMID: 42455567.

2. Arulampalam T, et al. Comparative study of robotic vs laparoscopic cholecystectomy: clinical and economic outcomes. Surg Endosc. 2020;

3. Jagim A, et al. Cost-effectiveness and clinical impact of robotic surgery in complex hepatobiliary procedures. HPB (Oxford). 2022;

4. Kulkarni AV, et al. Clinical and economic considerations of robotic versus laparoscopic cholecystectomy in complex disease. Ann Surg. 2024;

These references provide context on surgical approaches and health economics relevant to this study.